Guangli Biotechnology Holding Co., Ltd. announced a correction to its Q1 115 IFRSs iXBRL financial information. The correction pertains to the 'investee company name, location, and other related information', which was previously omitted or unlisted. The updated report comprehensively details original investment amounts, final shareholding ratios, and recognized investment gains and losses for multiple subsidiaries, including Novel Idea, Taiwan Guangli Industrial, and Alliance Capital. The corrected financial document will be re-uploaded to the Market Observation Post System.

FACT BOX

  • Source: PR Times
  • Category: 其他
  • Organizations: Novel Idea Co.,Ltd. / Alliance Capital Investment Management Inc.